BONARDI, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 234
EU - Europa 180
AS - Asia 112
SA - Sud America 17
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 548
Nazione #
US - Stati Uniti d'America 229
DE - Germania 93
CN - Cina 48
SG - Singapore 37
UA - Ucraina 27
RU - Federazione Russa 24
GB - Regno Unito 17
BR - Brasile 14
HK - Hong Kong 12
CZ - Repubblica Ceca 4
FI - Finlandia 4
IE - Irlanda 4
TR - Turchia 4
VN - Vietnam 4
CA - Canada 3
IT - Italia 3
JP - Giappone 3
IN - India 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
ES - Italia 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
SE - Svezia 1
VE - Venezuela 1
Totale 548
Città #
Ann Arbor 31
Fairfield 27
Jacksonville 20
Singapore 16
Ashburn 12
Dearborn 12
Hong Kong 12
Cambridge 11
Chandler 10
Houston 10
Munich 10
Wilmington 10
New York 9
Princeton 8
Woodbridge 8
Nanjing 7
Seattle 7
Beijing 6
Brno 4
Dublin 4
Los Angeles 4
Nürnberg 4
Shanghai 4
Istanbul 3
San Diego 3
San Francisco 3
Shenyang 3
Tokyo 3
Brooklyn 2
Buffalo 2
Hebei 2
Hefei 2
Helsinki 2
Johannesburg 2
Kunming 2
Moscow 2
Nanchang 2
Porto Alegre 2
Turku 2
Al Ain City 1
Ankara 1
Asunción 1
Biên Hòa 1
Brasília 1
Camapuã 1
Canoas 1
Changchun 1
Chennai 1
Chicago 1
Ciudad Nezahualcoyotl 1
Ciudad Ojeda 1
Cotia 1
Dallas 1
Des Moines 1
Guangzhou 1
Hangzhou 1
Heze 1
Ho Chi Minh City 1
Indaiatuba 1
Kansas City 1
Lanzhou 1
Loma Hermosa 1
Nairobi 1
New Albany 1
New Delhi 1
Newark 1
Nova Andradina 1
Orem 1
Poplar 1
Poços de Caldas 1
Providence 1
Quảng Ngãi 1
Raleigh 1
Ribeirão Preto 1
Rio Grande da Serra 1
Salvador 1
Stockholm 1
São José do Norte 1
São Luís 1
Taizhou 1
The Dalles 1
Tianjin 1
Verano Brianza 1
Wuhan 1
Xinxiang 1
Totale 329
Nome #
Hypoxia-related biological markers as predictors of epirubicinbased treatment responsiveness and resistance in locally advanced breast cancer 160
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 152
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen 124
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 121
Totale 557
Categoria #
all - tutte 2.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 6 3 5 4 8 5 1
2021/202229 3 7 1 1 2 0 2 2 3 1 1 6
2022/202331 4 0 1 1 1 11 0 5 7 0 1 0
2023/202430 2 0 4 0 0 7 1 1 6 0 1 8
2024/202573 1 1 1 8 4 4 10 4 8 4 15 13
2025/202682 19 17 12 16 18 0 0 0 0 0 0 0
Totale 557